Chiara Riganti

97PUBLICATIONS
324CO-AUTHORS
NanomedicinePredictive and prognostic markersOrganometallic chemistryProteins and peptidesMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Aug 13, 2026
Correction: Audrito et al. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers 2020, 12, 3855.

|Aug 11, 2026
RETRACTED: Schiavello et al. Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma. Cancers 2021, 13, 1138.

|Jun 12, 2026
(S,S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((1-(pyridin-4-yl)ethyl)amino)propan-2-yl)-1H-indole-2-carboxamide, a New Dishevelled 1 and P-Glycoprotein Dual Inhibitor as a Anticancer Agent.

|May 27, 2026
Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 2020, 9, 1033.

|Mar 27, 2026
Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spread.

Menga Alessio, Jessica Petiti, Roberta Basile

|Feb 20, 2026
Fraisinib in a Shell: Liposomal Encapsulation of a GARS1 Inhibitor for Controlled Anticancer Delivery.

Stefano Boetti, Ilaria Andreana, Barbara Rolando

Pageof 17

Frequent Collaborators

15 joint publications

Joanna Kopecka

13 joint publications

Marialessandra Contino

9 joint publications

Iris Chiara Salaroglio

8 joint publications

Barbara Rolando